Search for a research peptide and the same molecule comes back under four or five different names, each used confidently and none explained. The names are not interchangeable marketing variants. They come from different naming systems, each created for a different purpose, and knowing which system a name belongs to tells you something useful about where the compound sits and which literature will describe it.
Quick answer
Why does one peptide have several different names? Because several naming systems operate in parallel. A development code is assigned by the organisation that created the molecule. A generic name is assigned later through an international naming programme once a compound advances. A sequence abbreviation names the molecule by its amino acids. A descriptive or fragment name describes what it is or where it came from. All can refer to the same substance, and the sequence and CAS number on a certificate of analysis are the identifiers that settle it.
The four naming systems
| System | Who assigns it | What it tells you | Form |
|---|---|---|---|
| Development code | The organisation that developed the molecule | That the compound came out of a formal development programme | Letters plus digits, often the developer initials |
| Generic name (INN) | An international naming programme | That the compound advanced far enough to need a non-proprietary name; the stem often signals its class | A single lowercase word |
| Sequence abbreviation | Convention, from the amino acid codes | The actual composition, for short peptides | Letters matching residues, such as a three-letter string |
| Descriptive or fragment name | The original research literature | Origin, function or the parent protein a fragment came from | Words or an abbreviation plus a number |
A generic name carries real information. Many are built from stems that group related molecules, so compounds sharing a suffix usually share a mechanism class. That is a deliberate feature of the naming programme rather than a coincidence.
How this plays out across a catalog
The table below maps the names most often encountered for compounds in the Revoryn Labs catalog. It is a reading aid for literature searches, not a statement that every name is equivalent in every context.
| Compound | Also appears as | Naming system |
|---|---|---|
| RT | LY3437943 | Market abbreviation plus development code |
| TZ | LY3298176 | Market abbreviation plus development code |
| SM | NN9535 | Market abbreviation plus development code |
| PT-141 | Bremelanotide | Development code plus generic name |
| MT-2 | MT-II; MT2 | Abbreviation of a descriptive research name |
| BPC-157 | Body Protection Compound 157; pentadecapeptide BPC 157 | Descriptive name, with length noted in the literature |
| TB-500 | Discussed alongside thymosin beta-4, the parent protein of the region it corresponds to | Code name plus parent-protein reference |
| GHK-Cu | Glycyl-L-histidyl-L-lysine copper; copper tripeptide | Sequence abbreviation plus the bound metal |
| Epitalon | Epithalon; AEDG peptide | Descriptive name plus sequence abbreviation |
| MOTS-c | Mitochondrial ORF of the 12S rRNA type-c | Acronym describing genomic origin |
| KPV | A tripeptide corresponding to the C-terminal residues of alpha-MSH | Sequence abbreviation |
Two of those rows show the pattern most clearly. GHK is simply glycine, histidine and lysine written in one-letter code, so the name is the sequence; how to read a peptide sequence explains the codes, and why copper binding matters explains what the Cu adds. MOTS-c is an acronym describing where in the mitochondrial genome it is encoded, which is the whole point of the compound; see mitochondrial-derived peptides.
What a shared name does not mean
A name identifies a molecule. It says nothing about the material in a particular vial, and this is where naming most often misleads.
- Same name, different regulatory status. A research-grade compound and an approved pharmaceutical product can share a generic name while being entirely different things in manufacturing, testing and legal terms. PT-141 vs bremelanotide works through exactly that case.
- Same name, different salt form. The counter-ion is usually not in the name, yet it changes the mass of the powder; see TFA vs acetate.
- Same name, different modifications. An amidated C-terminus or an acetylated N-terminus can leave the common name unchanged while changing the molecular weight, which matters when converting to molar units; see peptide molarity.
- Same name, different purity and content. Nothing in any naming system describes what is actually in the vial. That is what a lot certificate is for; see net peptide content vs purity.
The identifiers that actually settle it
When two names might or might not describe the same substance, three fields on a certificate resolve the question, in this order of authority.
- The sequence. The amino acid order, written N-terminus to C-terminus, with any modifications noted. This is the molecule.
- The CAS registry number. A unique identifier for a defined chemical substance, independent of what anyone calls it.
- The molecular formula and molecular weight. A numerical cross-check that the sequence and the material agree, and the figures the mass spectrometry result is judged against.
All three appear on a well-constructed certificate, and the COA glossary defines each field. A vendor listing that gives a popular name and no sequence has not identified what it is selling.
Why this matters for a literature search
Searching a database under the wrong name is the most common reason a researcher concludes that little has been published on a compound. Development codes dominate the clinical and preclinical literature, generic names dominate later publications and regulatory documents, and descriptive names dominate the earliest reports and anything written for a general audience. A thorough search uses all of them, plus the CAS number.
It also matters commercially. Two listings under different names can be the same molecule at different prices, and comparing them requires normalising the name first and the mass second; see cost per milligram.
What to record
Record the name you ordered under, the sequence from the certificate, the CAS number, the molecular weight, any modifications, and the lot number. That set survives a change in common usage and lets anyone reconstruct exactly which molecule was studied. Revoryn Labs publishes available batch documentation, including sequence and analytical results, in its public COA ledger, and the catalog is organised by research area in a research buyer guide to the catalog.
Key takeaways
- Development codes, generic names, sequence abbreviations and descriptive names are four different systems, not synonyms of equal standing.
- A generic name often signals a compound class through its stem; a development code signals a formal development programme.
- Short peptides are frequently named by their own sequence, as with GHK and KPV.
- A shared name does not imply shared salt form, modifications, purity, content or regulatory status.
- Sequence, CAS number and molecular weight on the certificate are what identify the substance.
- Searching the literature under only one name is the usual reason a compound looks under-studied.
Frequently asked questions
Why is MT-2 written as an abbreviation?
MT-2 is the common abbreviation of a longer descriptive research name for the same synthetic melanocortin peptide. As always, the sequence on the certificate is what confirms identity for a given vial.
Why do some peptides have a code like LY3437943?
That is a development code assigned by the organisation that created the molecule. Codes of this kind appear throughout the preclinical and clinical literature and often predate the generic name.
Is a generic name the same as a brand name?
No. A generic name is a non-proprietary name assigned through an international programme and belongs to the substance. Brand names belong to specific approved products and are not used for research material.
What does GHK stand for?
It is the sequence itself, written in one-letter amino acid code: glycine, histidine and lysine. The Cu in GHK-Cu indicates the bound copper.
Which name should I use in my records?
Record the name you ordered under together with the sequence and CAS number from the certificate. Names change in popularity; the sequence does not.
Sources
- World Health Organization. International Nonproprietary Names (INN) programme. who.int
- IUPAC-IUB Joint Commission on Biochemical Nomenclature. Nomenclature and symbolism for amino acids and peptides. iupac.qmul.ac.uk
- Bachem. Quality Control of Amino Acids & Peptides: A Guide. bachem.com
For laboratory and in-vitro research use only. Not for human or veterinary use.
For laboratory and in-vitro research use only. Not for human or veterinary use. See our research-use disclaimer.
